Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
Chromosomes, Human, 19-20
Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage.
Cyperus
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma. Clin Cancer Res. 2022 06 01; 28(11):2306-2312.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Alkylating
B7-H1 Antigen
Humans
Leiomyosarcoma
Leukocytes, Mononuclear
Liposarcoma
authors with profiles
Robin Jones